Taking a clue from a rare disorder in which the immune system destroys a patient’s cancer even as it attacks the nervous system, researchers have devised a new strategy to fight breast and ovarian cancer. The scientists have engineered immune cells that target cells containing a protein found in up to 60 percent of ovarian tumors and 25 percent of breast tumors.
